Glucotrol XL: Advanced Glycemic Control for Type 2 Diabetes
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.49 | $44.24 (0%) | 🛒 Add to cart |
| 120 | $0.44 | $58.99 $52.28 (11%) | 🛒 Add to cart |
| 180 | $0.39 | $88.48 $69.38 (22%) | 🛒 Add to cart |
| 270 | $0.35 | $132.72 $93.51 (30%) | 🛒 Add to cart |
| 360 | $0.33
Best per pill | $176.96 $118.64 (33%) | 🛒 Add to cart |
Synonyms | |||
Glucotrol XL (glipizide) is an extended-release oral antihyperglycemic agent indicated as an adjunct to diet and exercise for the management of type 2 diabetes mellitus. As a second-generation sulfonylurea, it facilitates controlled insulin secretion from pancreatic beta cells, offering a predictable pharmacokinetic profile that supports sustained blood glucose reduction. Its advanced gastrointestinal therapeutic system (GITS) allows for once-daily dosing, promoting enhanced patient adherence and consistent 24-hour glycemic coverage, making it a cornerstone therapy in long-term diabetes management protocols.
Features
- Active ingredient: Glipizide (5 mg or 10 mg per tablet)
- Formulation: Extended-release tablet utilizing osmotic push-pull technology (GITS)
- Dosing frequency: Once daily, preferably with breakfast
- Onset of action: Within 2–3 hours post-administration
- Duration of effect: Up to 24 hours due to controlled release mechanism
- Bioavailability: Nearly 100% under fasting conditions
- Excretion: Primarily hepatic metabolism with renal elimination of metabolites
Benefits
- Provides consistent 24-hour glycemic control with a single daily dose, reducing fasting and postprandial hyperglycemia.
- Lowers HbA1c levels effectively by 1–2%, supporting long-term metabolic health and reducing diabetes-related complications.
- Minimizes peak-trough fluctuations in plasma drug concentrations, decreasing the risk of hypoglycemic events compared to immediate-release formulations.
- Supports patient compliance and quality of life through convenient dosing and reduced pill burden.
- Compatible with complementary therapies, including metformin, when additional glycemic control is necessary.
- Backed by extensive clinical evidence demonstrating efficacy and safety in diverse patient populations.
Common use
Glucotrol XL is primarily prescribed for adults with type 2 diabetes mellitus whose hyperglycemia cannot be adequately controlled by diet and exercise alone. It is often used as monotherapy or in combination with other antihyperglycemic agents, such as biguanides or insulin, depending on individualized treatment goals. It is not indicated for type 1 diabetes or diabetic ketoacidosis.
Dosage and direction
The recommended starting dose is 5 mg once daily, taken with breakfast. Dosage adjustments should be made in increments of 5 mg at weekly intervals based on blood glucose response, with a maximum recommended dose of 20 mg per day. Tablets must be swallowed whole and not crushed, chewed, or divided. Administration with food is advised to optimize gastrointestinal tolerance and ensure consistent absorption.
Precautions
- Regular monitoring of blood glucose and HbA1c is essential to evaluate therapeutic response and avoid hypoglycemia.
- Use with caution in elderly, debilitated, or malnourished patients, and those with adrenal or pituitary insufficiency, due to increased hypoglycemia risk.
- Hepatic or renal impairment may alter drug metabolism and excretion; dose reduction or alternative therapy may be necessary.
- Stressful conditions such as fever, trauma, or surgery may necessitate temporary insulin therapy.
- Educate patients on recognizing and managing hypoglycemia symptoms (e.g., sweating, tremor, confusion).
Contraindications
- Hypersensitivity to glipizide, other sulfonylureas, or any component of the formulation.
- Diabetic ketoacidosis, with or without coma.
- Severe renal or hepatic impairment.
- Pregnancy and lactation; insulin is the preferred therapy during these periods.
Possible side effects
- Common: Hypoglycemia, dizziness, headache, nausea, gas.
- Less common: Skin reactions (e.g., rash, pruritus), gastrointestinal discomfort, transient visual disturbances.
- Rare: Hematologic effects (e.g., leukopenia, thrombocytopenia), hyponatremia, disulfiram-like reactions, hepatic enzyme elevations.
- Severe but rare: Stevens-Johnson syndrome, hepatitis, hemolytic anemia.
Drug interaction
- Enhanced hypoglycemic effects with: insulin, other oral antidiabetics, ACE inhibitors, beta-blockers, fluconazole, sulfonamides, salicylates.
- Reduced efficacy with: thiazides, corticosteroids, phenothiazines, thyroid products, estrogens, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, isoniazid.
- Beta-blockers may mask hypoglycemia symptoms.
- Alcohol may precipitate disulfiram-like reactions or alter glycemic control.
Missed dose
If a dose is missed, it should be taken as soon as remembered the same day. If it is near the time of the next dose, skip the missed dose and resume the regular schedule. Do not double the dose.
Overdose
Symptoms: Severe hypoglycemia (sweating, tremor, seizures, coma). Management: Immediate glucose administration (oral or intravenous). Close monitoring and supportive care are essential; hospitalization may be required for severe cases.
Storage
Store at room temperature (20–25°C/68–77°F) in a tightly closed container, protected from light and moisture. Keep out of reach of children and pets. Do not use beyond the expiration date.
Disclaimer
This information is for educational purposes and does not replace professional medical advice. Always consult a healthcare provider for diagnosis, treatment decisions, and individualized dosing. Use only as directed.
Reviews
Clinical studies and post-marketing surveillance demonstrate that Glucotrol XL is effective in maintaining glycemic control with a favorable side effect profile. Patients report improved convenience and quality of life due to once-daily dosing. Healthcare providers value its predictability and compatibility with combination therapies. Long-term data support its role in reducing microvascular complications associated with type 2 diabetes.